Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
FOLD holding history
Amicus Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −255,618−100.0% | Sold out | Holders |
| Q1 2026 | 255,618 | $3.70M | <0.1% | +2,784+1.1% | Added | Holders |
| Q4 2025 | 252,834 | $3.60M | <0.1% | +104,781+70.8% | Added | Holders |
| Q3 2025 | 148,053 | $1.17M | <0.1% | −18,022−10.9% | Reduced | Holders |
| Q2 2025 | 166,075 | $951.6K | <0.1% | −56,173−25.3% | Reduced | Holders |
| Q1 2025 | 222,248 | $1.81M | <0.1% | −19,367−8.0% | Reduced | Holders |
| Q4 2024 | 241,615 | $2.28M | <0.1% | +14,562+6.4% | Added | Holders |
| Q3 2024 | 227,053 | $2.42M | <0.1% | −3,984−1.7% | Reduced | Holders |
| Q2 2024 | 231,037 | $2.29M | <0.1% | +231,037 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −211,895−100.0% | Sold out | Holders |
| Q3 2023 | 211,895 | $2.58M | <0.1% | +2,716+1.3% | Added | Holders |
| Q2 2023 | 209,179 | $2.63M | <0.1% | +209,179 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −153,069−100.0% | Sold out | Holders |
| Q3 2022 | 153,069 | $1.60M | <0.1% | −13,128−7.9% | Reduced | Holders |
| Q2 2022 | 166,197 | $1.78M | <0.1% | −121,599−42.3% | Reduced | Holders |
| Q1 2022 | 287,796 | $2.73M | <0.1% | −34,672−10.8% | Reduced | Holders |
| Q4 2021 | 322,468 | $3.73M | <0.1% | −4,242−1.3% | Reduced | Holders |
| Q3 2021 | 326,710 | $3.12M | <0.1% | −21,731−6.2% | Reduced | Holders |
| Q2 2021 | 348,441 | $3.36M | <0.1% | +348,441 | New | Holders |